TITLE
DNA methyltransferase inhibitor 5-aza-2-deoxycytidine effect on RAS-transformed fibroblasts

SUMMARY
Expression profiling of HRAS oncogene transformed fibroblasts after treatment with the DNA methyltransferase inhibitor 5-aza-2-deoxycytidine for 96 hours. Results provide insight into the role of DNA methylation in oncogenic signaling pathways.

ORGANISM
Rattus norvegicus

PLATFORM
GPL85 : [RG_U34A] Affymetrix Rat Genome U34 Array

CITATIONS
Lund P, Weisshaupt K, Mikeska T, Jammas D et al. Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation. Oncogene 2006 Aug 10;25(35):4890-903. PMID:Â  16568090

